Renato Goreshi, MD
MOHS-Micrographic Surgery · Merrillville, INNPI 1235450420
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 47 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations.
Across 47 payments — averaging $19.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$201
- AbbVie$141
- UCB, Inc.$89
- Kerecis Limited$71
- Organogenesis Inc.$69
- Smith+Nephew$48
- plus $308 from 11 others
What the payments were for
- Food & beverage$927100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 8 | $201 |
| AbbVie(2 entities) | 8 | $141 |
| UCB, Inc. | 3 | $89 |
| Kerecis Limited | 6 | $71 |
| Organogenesis Inc. | 3 | $69 |
| Smith+Nephew | 2 | $48 |
| Sanofi | 2 | $47 |
| Dermavant Sciences, Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $35 |
| Mayne Pharma Commercial LLC | 1 | $33 |
| Mimedx Group, Inc. | 2 | $31 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $29 |
| Galderma Laboratories, L.p. | 2 | $27 |
| Bristol Myers Squibb | 1 | $21 |
| Pfizer | 1 | $18 |
| Botanix SB Inc | 1 | $18 |
| Novartis | 1 | $13 |
How this compares
Too few mohs-micrographic surgery providers in Indianato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 31 | $2,149 |
| Clobetasol Propionate | 45 | $1,495 |
| Doxycycline Hyclate | 63 | $1,148 |
| Fluocinonide | 32 | $1,026 |
| Metronidazole | 18 | $844 |
| Ketoconazole | 21 | $478 |
| Triamcinolone Acetonide | 54 | $467 |
| Mupirocin | 32 | $362 |
| Doxycycline Monohydrate | 18 | $353 |
| Imiquimod | 14 | $338 |
| Nystatin | 25 | $298 |
| Amoxicillin | 46 | $116 |
| Hydrocortisone | 23 | $103 |
| Cephalexin | 13 | $54 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Merrillville
- Carl HankeIndianapolis$96K
- Rachel WardMuncie$9K
- Eduardo RiveraMadison$8K
- John RandallWest Lafayette$6K
- David SurprenantEvansville$5K
- Brian WilliamsGreenwood$5K
- Perry HooperCarmel$5K
- Shayna GordonPlainfield$4K
- Jane LimEvansville$4K
- Thomas McGovernFort Wayne$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.